ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

NCI Sends A Second Letter To Groups About Carboplatin

October 22, 2010

Grant, contract Awards Held Up By Impasse On Appropriations

October 14, 1977

Clinical Trials: Stories On Results Can Have Unintended Consequences

May 15, 1998

Greenwald Disagrees With WHT Report But Won’t Fight Decision; Will Ask For Limited Study, With Scope To Be Modified

January 15, 1988

Cancer Letter Adds Associate Editor

July 19, 1985

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

July 25, 1975